Abstract

Escherichia coli commonly occurs as a normal flora found in a variety of gastrointestinal tracts. However, certain strains acquire virulence characteristics. Potentially pathogenic species have also been isolated in non-clinical environments.This often raises concerns on the role these environments play in transmission. This study aimed to assess the occurrence of virulence traits in Escherichia coli isolated from non-clinical and clinical sources in Port Harcourt, Nigeria. Two hundred samples from clinical (urine and stool) and non-clinical (soil and poultry) sources were analyzed. 8 isolation, purification and identification of E. coli isolates were performed using standard bacteriological and biochemical tests. Out of the 200 samples collected, 98 isolates (49%) were confirmed as E. coli. Confirmed E. coli isolates were then tested for virulence using standard phenotypic tests (protease, colicin, congo red, hemolysin, haemagglutination, adhesin and mannose resistant/sensitive haemagglutination). E. coli strains from clinical samples displayed a number of virulence traits ranging frombiofilm producing capabilities (53%), congo red binding propensity (24%), colicin (34%), protease (15%) and hemolysin production (4%) compared to their non-clinical counterpart. All samples were negative for haemagglutination. The total virulence prevalence of E. coli was 81%. Clinical samples possessed more virulence traits (71%) than samples from non-clinical sources (29%), with urine having a higher occurrence among the clinical samples (36%). There is need for an in-depth study on virulence attributes of E. coli and ways to control these factors to minimize the rate of spread and the degree of infections.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call